Medical management of chronic heart failure in children

American Journal of Cardiovascular Drugs

Volumn 1, Issue 1, 2001, Pages 37-44

  Ross, Robert D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; BLOOD; CHILD; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIET THERAPY; HUMAN; INFANT; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CHILD; CLINICAL TRIALS; DIGOXIN; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; NEUROTRANSMITTER AGENTS; NUTRITION THERAPY;

EID: 0038041618     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/00129784-200101010-00004     Document Type: Review

References (31)

1. Waller DG. Effect of drug treatment on quality of life in mild to moderate heart failure. Drug Saf 1991; 6 (4): 241-6
2. Mosterd A, Deckers JW, Hoes AW, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997; 13: 491-502
3. Ross RD, Daniels SR, Schwartz DC, et al. Plasma norepinephrine levels in infants and children with congestive failure. Am J Cardiol 1987 Apr 1; 59: 911-4
4. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol 1992; 13 (2): 72-5
5. Kohya T, Tsuzuki N, Kaji T, et al. Effects of the aldosterone antagonist spironolactone on ventricular arrhythmias and serum electrolyte levels in congestive heart failure. Clin Drug Invest 1995; 10 (5): 264-75
6. Alon US, Scagliotti D, Garola RE. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr 1994 Jul; 125 (1): 149-51
7. Clegg HW, Riopel DA. Furosemide-associated fever. J Pediatr 1995 May; 126 (5): 817-8
8. Vaisman N, Leigh T, Voet H, et al. Malabsorption in infants with congenital heart disease under diuretic treatment. Pediatr Res 1994 Oct; 36 (4): 545-9
9. Heymsfield SB, Smith JS, Redd S, et al. Nutritional support in cardiac failure. Surg Clin North Am 1981; 61: 635-52
10. Kimball TR, Daniels SR, Meyer RA, et al. Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect. Am J Cardiol 1991 Nov 15; 68: 1377-82
11. Seguchi M, Nakazawa M, Momma K. Further evidence suggesting a limited role of digitalis in infants with circulatory congestion secondary to large ventricular septal defect. Am J Cardiol 1999 May 1; 83 (9): 1408-11
12. Newton GE, Tong JH, Schofield AM, et al. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol 1996 Jul; 28: 155-61
13. Ross RD, Daniels SR, Schwartz DC, et al. Return of plasma norepinephrine to normal after resolution of congestive heart failure in congenital heart disease. Am J Cardiol 1987 Dec 1; 60: 1411-3
14. Francis GS, Cohn JN, Johnson G, et al. Plasma norepinephrine, plasma renin activity, and congestive heart failure-relations to survival and the effects of therapy in V-HeFT II. Circulation 1993 Jun; 87 (6 Suppl.): VI40-8
15. Hornig B, Drexler H. Endothelial functions and bradykinin in humans. Drugs 1997; 54 Suppl. 5: 42-7
16. Wu JR, Chang HR, Huang TY, et al. Reduction in lymphocyte a-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease. Am J Cardiol 1996 Jan 15; 77: 170-4
17. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35
18. Lewis AB, Chabot M. The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy. Pediatr Cardiol 1993; 14 (1): 9-12
19. Montigny M, Davignon A, Fouron JC, et al. Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt. Am J Cardiol 1989 Mar 1; 63: 631-3
20. Webster MWI, Neutze JM, Calder AL. Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts. Pediatr Cardiol 1992; 13 (3): 129-35
21. Sluysmans T, Styns-Cailteux M, Tremouroux-Wattiez M, et al. Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy. Am J Cardiol 1992 Oct 1; 70: 959-62
22. Leversha AM, Wilson NJ, Clarkson PM, et al. Efficacy and dosage of enalapril in congenital and acquired heart disease. Arch Dis Child 1994 Jan; 70 (1): 35-9
23. Nakamura H, Ishii M, Sugimura T, et al. The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure. Clin Pharmacol Ther 1994 Aug; 56 (2): 160-8
24. Gleason MM, Roloff JS, Cyran SE, et al. Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21. Pediatr Cardiol 1993 Oct; 14 (3): 227-9
25. Hjalmarson A, Kneider M, Waagstein F. The role of a-blockers in left ventricular dysfunction and heart failure. Drugs 1997 Oct; 54 (4); 501-10
26. Shaddy RE, Tani LY, Gidding SS, et al. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 1999 Mar; 18 (3): 269-74
27. Buchhorn R, Bartmus D, Siekmeyer W, et al. Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts. Am J Cardiol 1998; 81: 1366-8
28. Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999 Apr 15; 83 (8): 1201-5
29. Horenstein MS, Ross RD, Singh TP, et al. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy. Pediatr Cardiol. In press
30. Pierpont MEM, Breningstall GN, Stanley CA, et al. Familial carnitine transporter defect: a treatable cause of cardiomyopathy in children. Am Heart J 2000 Feb; 139 (2): S96-106
31. Silverman BL, Friedlander JR. Is growth hormone good for the heart? J Pediatr 1997 Jul; 131 (1): S70-4